510 related articles for article (PubMed ID: 31639376)
1. Stem cell-based therapies for Duchenne muscular dystrophy.
Sun C; Serra C; Lee G; Wagner KR
Exp Neurol; 2020 Jan; 323():113086. PubMed ID: 31639376
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K
Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121
[TBL] [Abstract][Full Text] [Related]
3. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
[TBL] [Abstract][Full Text] [Related]
4. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
[TBL] [Abstract][Full Text] [Related]
5. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
Lala-Tabbert N; Fu D; Wiper-Bergeron N
Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
[TBL] [Abstract][Full Text] [Related]
6. Stem cell therapies to treat muscular dystrophy: progress to date.
Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
[TBL] [Abstract][Full Text] [Related]
7. Induced Fetal Human Muscle Stem Cells with High Therapeutic Potential in a Mouse Muscular Dystrophy Model.
Zhao M; Tazumi A; Takayama S; Takenaka-Ninagawa N; Nalbandian M; Nagai M; Nakamura Y; Nakasa M; Watanabe A; Ikeya M; Hotta A; Ito Y; Sato T; Sakurai H
Stem Cell Reports; 2020 Jul; 15(1):80-94. PubMed ID: 32619494
[TBL] [Abstract][Full Text] [Related]
8. Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts.
Iyer PS; Mavoungou LO; Ronzoni F; Zemla J; Schmid-Siegert E; Antonini S; Neff LA; Dorchies OM; Jaconi M; Lekka M; Messina G; Mermod N
Mol Ther; 2018 Apr; 26(4):1093-1108. PubMed ID: 29503200
[TBL] [Abstract][Full Text] [Related]
9. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy.
Péault B; Rudnicki M; Torrente Y; Cossu G; Tremblay JP; Partridge T; Gussoni E; Kunkel LM; Huard J
Mol Ther; 2007 May; 15(5):867-77. PubMed ID: 17387336
[TBL] [Abstract][Full Text] [Related]
10. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro.
Vieira NM; Brandalise V; Zucconi E; Jazedje T; Secco M; Nunes VA; Strauss BE; Vainzof M; Zatz M
Biol Cell; 2008 Apr; 100(4):231-41. PubMed ID: 17997718
[TBL] [Abstract][Full Text] [Related]
11. Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy.
Siemionow M; Cwykiel J; Heydemann A; Garcia J; Marchese E; Siemionow K; Szilagyi E
Stem Cell Rev Rep; 2018 Jun; 14(3):370-384. PubMed ID: 29546607
[TBL] [Abstract][Full Text] [Related]
12. [Cell therapy for Duchenne muscular dystrophy].
Zhou C; Zhang C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):659-61. PubMed ID: 17160947
[TBL] [Abstract][Full Text] [Related]
13. Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion.
Gonçalves MA; de Vries AA; Holkers M; van de Watering MJ; van der Velde I; van Nierop GP; Valerio D; Knaän-Shanzer S
Hum Mol Genet; 2006 Jan; 15(2):213-21. PubMed ID: 16321987
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update.
Sun C; Shen L; Zhang Z; Xie X
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32717791
[TBL] [Abstract][Full Text] [Related]
15. Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy.
Ostrovidov S; Shi X; Sadeghian RB; Salehi S; Fujie T; Bae H; Ramalingam M; Khademhosseini A
Stem Cell Rev Rep; 2015 Dec; 11(6):866-84. PubMed ID: 26323256
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR).
Elhussieny A; Nogami K; Sakai-Takemura F; Maruyama Y; Takemura N; Soliman WT; Takeda S; Miyagoe-Suzuki Y
Stem Cell Res Ther; 2021 Oct; 12(1):532. PubMed ID: 34627382
[TBL] [Abstract][Full Text] [Related]
17. Cell therapy in Duchenne muscular dystrophy treatment: clinical trials overview.
Bajek A; Porowinska D; Kloskowski T; Brzoska E; Ciemerych MA; Drewa T
Crit Rev Eukaryot Gene Expr; 2015; 25(1):1-11. PubMed ID: 25955813
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
[TBL] [Abstract][Full Text] [Related]
19. Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients.
Torrente Y; Belicchi M; Marchesi C; D'Antona G; Cogiamanian F; Pisati F; Gavina M; Giordano R; Tonlorenzi R; Fagiolari G; Lamperti C; Porretti L; Lopa R; Sampaolesi M; Vicentini L; Grimoldi N; Tiberio F; Songa V; Baratta P; Prelle A; Forzenigo L; Guglieri M; Pansarasa O; Rinaldi C; Mouly V; Butler-Browne GS; Comi GP; Biondetti P; Moggio M; Gaini SM; Stocchetti N; Priori A; D'Angelo MG; Turconi A; Bottinelli R; Cossu G; Rebulla P; Bresolin N
Cell Transplant; 2007; 16(6):563-77. PubMed ID: 17912948
[TBL] [Abstract][Full Text] [Related]
20. Duchenne muscular dystrophy hiPSC-derived myoblast drug screen identifies compounds that ameliorate disease in mdx mice.
Sun C; Choi IY; Rovira Gonzalez YI; Andersen P; Talbot CC; Iyer SR; Lovering RM; Wagner KR; Lee G
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32343677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
